Digital health funding held steady in the first half of 2025, with AI-focused startups capturing the majority of capital and driving rapid adoption among providers. The digital health space also saw two long-awaited IPOs as well as rising M&A activity, which are two signals of market maturity — but looming policy shifts may challenge long-term…
The real change with AI will happen not when everyone adopts the technology, which is happening quickly, but when these AIs can actually communicate and coordinate with one another. The post The AI Drug Discovery Boom Is Coming. We Are Not Ready. appeared first on MedCity News.
WellTheory launched a postpartum program to help women manage autoimmune symptoms triggered by hormonal changes after childbirth. The post WellTheory Introduces Autoimmune Postpartum Program appeared first on MedCity News.
Valora Therapeutics’ antibody lectin chimeras, or AbLecs, target glyco-immune checkpoints, pathways that modulate cellular communication with the immune system. The startup’s science is based on research from Carolyn Bertozzi, a Stanford professor who was awarded the 2022 Nobel Prize in Chemistry. The post Startup Valora Unveils a Sweet Way to Stop Cancer and Autoimmune Disease,…
VBC does not necessarily mean a reduction in all utilization. Rather, it means a rebalancing: fewer avoidable admissions, but possibly more use of home-based care, ambulatory services, and proactive outreach. The post The VBC Paradox: How Health Systems Can Balance Inpatient Revenue With Value-Based Care Goals appeared first on MedCity News.
Seaport Therapeutics’ Series B financing was one of the largest rounds of funding in our recap of biotech financing news, which spans startups developing drugs for neurological diseases, cancer, immunology, and more. The post Seaport Therapeutics Secures $225M for New Kind of Depression Drug appeared first on MedCity News.
At Forbes Healthcare Summit, Epic CEO Judy Faulkner explained why the company’s long-protected independence and unconventional management approach have been central to its dominance as an EHR vendor. Now, she says the company’s future will depends on how it uses its massive data stores to support AI-powered clinical decisions. The post Why Epic’s Judy Faulkner…
By GEORGE HALVORSON I have been railing against the Electoral College (and the Senate) as anti-democratic forever, and no one much cares. Turns out George Halvorson noticed–Matthew Holt We all need to remember that Joe Biden got 11,110,258 California votes in the last election and we need to know and remember that Donald Trump got…
Positive preliminary results for Eli Lilly’s efsitora alfa continue to build the case for this once-weekly insulin in type 2 diabetes patients. Lilly is trying to catch up to Novo Nordisk’s once weekly insulin icodec, which is commercially available in several markets around the world but is not yet approved by the FDA. The post…
What if the kind of cuts we should be talking about are the ones that actually make care better? Like cutting confusion. Because for many people, the biggest barrier to healthcare access isn’t cost or availability – it’s complexity. The post A Call for Healthcare Cuts — But Not the Kind You’re Thinking Of appeared…